| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Dimerix Bioscience is a public unlisted clinical stage drug discovery and development company, based in Melbourne. Dimerix’s lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200. This study has repurposing of existing molecules at its core, and upon successful results from this study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication. The study has been initiated at the Austin Hospital under the supervision of Professor Power, and is currently recruiting patients. |
| Category: | Health & biotech |
| URL: | http://dimerix.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2004 |
| Address: | Dimerix Bioscience Limited |
| State: | Victoria, Western Australia |
| Overseas Operations: | No |
| Twitter: | [twitter-timeline username=”“] |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/dimerix-bioscience?trk=top_nav_home |
| Founders: |
No items found
|
| Awards won: | |
